Correlation Between Compass Therapeutics and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Compass Therapeutics and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compass Therapeutics and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Compass Therapeutics and Candel Therapeutics, you can compare the effects of market volatilities on Compass Therapeutics and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compass Therapeutics with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compass Therapeutics and Candel Therapeutics.
Diversification Opportunities for Compass Therapeutics and Candel Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Compass and Candel is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Compass Therapeutics and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Compass Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compass Therapeutics are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Compass Therapeutics i.e., Compass Therapeutics and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Compass Therapeutics and Candel Therapeutics
Given the investment horizon of 90 days Compass Therapeutics is expected to generate 0.75 times more return on investment than Candel Therapeutics. However, Compass Therapeutics is 1.33 times less risky than Candel Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Candel Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 170.00 in Compass Therapeutics on September 5, 2024 and sell it today you would lose (8.00) from holding Compass Therapeutics or give up 4.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Compass Therapeutics vs. Candel Therapeutics
Performance |
| Timeline |
| Compass Therapeutics |
| Candel Therapeutics |
Compass Therapeutics and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Compass Therapeutics and Candel Therapeutics
The main advantage of trading using opposite Compass Therapeutics and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compass Therapeutics position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Compass Therapeutics vs. Candel Therapeutics | Compass Therapeutics vs. Cingulate Warrants | Compass Therapeutics vs. Unicycive Therapeutics | Compass Therapeutics vs. Cardio Diagnostics Holdings |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |